Article Summary

The Supreme Court kept mail access to the abortion pill mifepristone in place while legal challenges continue, allowing patients across the country to keep receiving the medication by mail. The article emphasizes concerns from providers and drug manufacturers about confusion and harm if mail access were blocked, and highlights Louisiana's effort to stop out-of-state abortions but doesn't dig into broader legal debates over federal versus state power. It clearly supports uninterrupted access by focusing on patient safety and medical necessity, using strong language and expert sources to underscore the stakes for people in restrictive states.